The NanoBase™ Standard: A Clinical Audit of Next-Generation Bioavailability Architecture in Formulation

For decades, the skincare industry has relied on outdated HLB logic that prioritizes jar stability over skin performance. In this clinical audit, Med Spa Director Jaime Turgeon explores why architecture is the new limiting factor in skincare. From stabilizing impossible 16% peptide loads to achieving "iteration velocity" in manufacturing, discover how NanoBase™ is establishing a new baseline for functional bioavailability and predictable clinical outcomes.